vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and LINCOLN EDUCATIONAL SERVICES CORP (LINC). Click either name above to swap in a different company.

CORCEPT THERAPEUTICS INC is the larger business by last-quarter revenue ($202.1M vs $142.9M, roughly 1.4× LINCOLN EDUCATIONAL SERVICES CORP). CORCEPT THERAPEUTICS INC runs the higher net margin — 12.0% vs 8.9%, a 3.1% gap on every dollar of revenue. On growth, LINCOLN EDUCATIONAL SERVICES CORP posted the faster year-over-year revenue change (19.7% vs 11.1%). CORCEPT THERAPEUTICS INC produced more free cash flow last quarter ($38.4M vs $25.0M). Over the past eight quarters, LINCOLN EDUCATIONAL SERVICES CORP's revenue compounded faster (17.6% CAGR vs 17.3%).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Lincoln Tech is an American group of for-profit postsecondary vocational institutions headquartered in Parsippany, New Jersey with campuses in Colorado, Connecticut, Georgia, Illinois, Indiana, Maryland, New Jersey, New York, Pennsylvania, Rhode Island, Tennessee, and Texas. Each campus is owned and operated by Lincoln Educational Services Corporation, a provider of career-oriented post-secondary education.

CORT vs LINC — Head-to-Head

Bigger by revenue
CORT
CORT
1.4× larger
CORT
$202.1M
$142.9M
LINC
Growing faster (revenue YoY)
LINC
LINC
+8.6% gap
LINC
19.7%
11.1%
CORT
Higher net margin
CORT
CORT
3.1% more per $
CORT
12.0%
8.9%
LINC
More free cash flow
CORT
CORT
$13.4M more FCF
CORT
$38.4M
$25.0M
LINC
Faster 2-yr revenue CAGR
LINC
LINC
Annualised
LINC
17.6%
17.3%
CORT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CORT
CORT
LINC
LINC
Revenue
$202.1M
$142.9M
Net Profit
$24.3M
$12.7M
Gross Margin
98.7%
62.3%
Operating Margin
2.2%
12.4%
Net Margin
12.0%
8.9%
Revenue YoY
11.1%
19.7%
Net Profit YoY
-21.0%
85.9%
EPS (diluted)
$0.20
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
LINC
LINC
Q4 25
$202.1M
$142.9M
Q3 25
$207.6M
$141.4M
Q2 25
$194.4M
$116.5M
Q1 25
$157.2M
$117.5M
Q4 24
$181.9M
$119.4M
Q3 24
$182.5M
$114.4M
Q2 24
$163.8M
$102.9M
Q1 24
$146.8M
$103.4M
Net Profit
CORT
CORT
LINC
LINC
Q4 25
$24.3M
$12.7M
Q3 25
$19.7M
$3.8M
Q2 25
$35.1M
$1.6M
Q1 25
$20.5M
$1.9M
Q4 24
$30.7M
$6.8M
Q3 24
$47.2M
$4.0M
Q2 24
$35.5M
$-682.0K
Q1 24
$27.8M
$-214.0K
Gross Margin
CORT
CORT
LINC
LINC
Q4 25
98.7%
62.3%
Q3 25
97.8%
59.5%
Q2 25
98.2%
59.8%
Q1 25
98.5%
59.7%
Q4 24
98.4%
62.2%
Q3 24
98.4%
58.0%
Q2 24
98.5%
55.7%
Q1 24
98.3%
58.4%
Operating Margin
CORT
CORT
LINC
LINC
Q4 25
2.2%
12.4%
Q3 25
4.9%
4.4%
Q2 25
13.7%
2.5%
Q1 25
2.2%
2.9%
Q4 24
13.9%
9.2%
Q3 24
25.5%
5.1%
Q2 24
21.7%
-1.1%
Q1 24
20.1%
-0.4%
Net Margin
CORT
CORT
LINC
LINC
Q4 25
12.0%
8.9%
Q3 25
9.5%
2.7%
Q2 25
18.1%
1.3%
Q1 25
13.1%
1.7%
Q4 24
16.9%
5.7%
Q3 24
25.9%
3.5%
Q2 24
21.7%
-0.7%
Q1 24
18.9%
-0.2%
EPS (diluted)
CORT
CORT
LINC
LINC
Q4 25
$0.20
$0.41
Q3 25
$0.16
$0.12
Q2 25
$0.29
$0.05
Q1 25
$0.17
$0.06
Q4 24
$0.25
$0.22
Q3 24
$0.41
$0.13
Q2 24
$0.32
$-0.02
Q1 24
$0.25
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
LINC
LINC
Cash + ST InvestmentsLiquidity on hand
$372.2M
$28.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$647.8M
$199.7M
Total Assets
$836.7M
$493.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
LINC
LINC
Q4 25
$372.2M
$28.5M
Q3 25
$421.7M
$13.5M
Q2 25
$342.2M
$16.7M
Q1 25
$322.8M
$28.7M
Q4 24
$383.3M
$59.3M
Q3 24
$380.3M
$54.0M
Q2 24
$473.2M
$67.0M
Q1 24
$410.8M
$68.6M
Stockholders' Equity
CORT
CORT
LINC
LINC
Q4 25
$647.8M
$199.7M
Q3 25
$631.9M
$185.9M
Q2 25
$635.8M
$180.7M
Q1 25
$683.3M
$177.8M
Q4 24
$679.6M
$178.3M
Q3 24
$638.8M
$170.0M
Q2 24
$596.2M
$164.9M
Q1 24
$547.9M
$164.5M
Total Assets
CORT
CORT
LINC
LINC
Q4 25
$836.7M
$493.2M
Q3 25
$823.6M
$466.9M
Q2 25
$801.7M
$447.3M
Q1 25
$846.5M
$427.4M
Q4 24
$840.6M
$436.6M
Q3 24
$784.3M
$404.0M
Q2 24
$714.6M
$366.4M
Q1 24
$655.9M
$355.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
LINC
LINC
Operating Cash FlowLast quarter
$38.4M
$43.5M
Free Cash FlowOCF − Capex
$38.4M
$25.0M
FCF MarginFCF / Revenue
19.0%
17.5%
Capex IntensityCapex / Revenue
0.0%
13.0%
Cash ConversionOCF / Net Profit
1.58×
3.43×
TTM Free Cash FlowTrailing 4 quarters
$-27.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
LINC
LINC
Q4 25
$38.4M
$43.5M
Q3 25
$54.5M
$23.9M
Q2 25
$43.9M
$299.0K
Q1 25
$5.1M
$-8.4M
Q4 24
$59.3M
$30.3M
Q3 24
$73.8M
$5.6M
Q2 24
$41.2M
$8.3M
Q1 24
$23.8M
$-14.9M
Free Cash Flow
CORT
CORT
LINC
LINC
Q4 25
$38.4M
$25.0M
Q3 25
$2.0M
Q2 25
$43.9M
$-26.1M
Q1 25
$5.0M
$-28.3M
Q4 24
$59.2M
$5.5M
Q3 24
$72.2M
$-13.8M
Q2 24
$40.8M
$-2.7M
Q1 24
$-16.6M
FCF Margin
CORT
CORT
LINC
LINC
Q4 25
19.0%
17.5%
Q3 25
1.4%
Q2 25
22.6%
-22.4%
Q1 25
3.2%
-24.1%
Q4 24
32.5%
4.6%
Q3 24
39.5%
-12.0%
Q2 24
24.9%
-2.6%
Q1 24
-16.1%
Capex Intensity
CORT
CORT
LINC
LINC
Q4 25
0.0%
13.0%
Q3 25
0.0%
15.5%
Q2 25
0.0%
22.7%
Q1 25
0.1%
16.9%
Q4 24
0.1%
20.8%
Q3 24
0.9%
16.9%
Q2 24
0.3%
10.7%
Q1 24
0.0%
1.6%
Cash Conversion
CORT
CORT
LINC
LINC
Q4 25
1.58×
3.43×
Q3 25
2.77×
6.29×
Q2 25
1.25×
0.19×
Q1 25
0.25×
-4.31×
Q4 24
1.93×
4.43×
Q3 24
1.56×
1.42×
Q2 24
1.16×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORT
CORT

Segment breakdown not available.

LINC
LINC

Transferred Over Time$136.0M95%
Transferred At Point In Time$6.9M5%

Related Comparisons